Complete Story
07/01/2020
The PADCEV (enfortumab vedotin-ejfv) Jcode is now available
We are sending this communication on behalf of Astellas Pharma US, Inc. and Seattle Genetics to announce the assignment of a product-specific, permanent J-code for PADCEV. The Centers for Medicare & Medicaid Services (CMS) released the July 2020 Quarterly Healthcare Common Procedural Coding System (HCPCS) File, which includes the designation of J9177 for PADCEV with the effective date of July 1, 2020.1 |
|||||||||||||
|
|||||||||||||
|